Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Antigen processing and presentation | R-HSA-1236975 | map04612 | indoprofen | 5280567 | drug-path |
| Asthma | R-HSA-444620 | map05310 | indoprofen | 5280567 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | indoprofen | 5280567 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | indoprofen | 5280567 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | indoprofen | 5280567 | drug-path |
| Shigellosis | 0 | map05131 | indoprofen | 5280567 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | indoprofen | 5280567 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | yohimbine | 8969 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | yohimbine | 8969 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | yohimbine | 8969 | drug-path |
| Adipocytokine signaling pathway | R-HSA-168638 | map04920 | yohimbine | 8969 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | yohimbine | 8969 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | yohimbine | 8969 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | BW-B70C | 5282169 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | BW-B70C | 5282169 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | BW-B70C | 5282169 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | cytochalasin B | 5311281 | drug-path |
| ErbB signaling pathway | R-HSA-168638 | map04012 | cytochalasin B | 5311281 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | phentolamine | 5775 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | phentolamine | 5775 | drug-path |